Claritev Corporation reports developments for a healthcare technology, data and insights company serving the U.S. healthcare system. The company provides technology-enabled solutions built on claims expertise, advanced analytics and AI to support affordability, price transparency, payment integrity, network optimization and benefits design for payers, employers, patients, providers and third parties.
Recurring news includes quarterly results, guidance, investor-day strategy, conference participation, AI-focused leadership and workflow updates, product-roadmap themes and Claritev Cares community initiatives. Company updates often connect its analytics platform with healthcare cost management, revenue integrity and vertical-market expansion.
Claritev (NYSE: CTEV) announced that its management team will meet with investors at two conferences in December 2026. Management will present at 7:30 a.m. ET on December 1 at the BofA Securities Leveraged Finance Conference and join a fireside chat at 12:00 p.m. ET on December 3 at the Piper Sandler 38th Annual Healthcare Conference. Live webcasts and audio archives will be available on Claritev’s investor relations website.
Claritev (CTEV) reported third-quarter 2026 revenue of $268.3 million and raised its full-year revenue, adjusted earnings and free cash flow guidance. Revenue grew 9.1% year over year. Net loss narrowed to $61.8 million from $69.8 million, while loss per share narrowed to $3.64 from $4.23. Adjusted EBITDA, a non-GAAP earnings measure, rose 4.4% to $162.0 million, but its margin fell to 60.4% from 63.1%.
Operating cash flow declined to $18.1 million from $19.9 million, and free cash flow worsened to negative $25.8 million from negative $16.3 million. Unrestricted cash ended the quarter at $10.1 million. Claritev now expects 2026 revenue of $1.038 billion to $1.043 billion, adjusted EBITDA of $625 million to $630 million and free cash flow of $10 million to $20 million. Its preliminary 2027 revenue expectation is $1.1 billion.
Claritev (CTEV) will participate in the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum on November 11, 2026.
Members of its management team will attend the forum in New York, with a presentation scheduled for 3:30 p.m. ET. A webcast will be available through the company's investor website.
Claritev (CTEV) launched Transparency-Based Pricing, a reimbursement intelligence solution for healthcare payers and third-party administrators that uses public transparency data.
The solution uses AI-enabled processes to standardize more than 1.7 trillion machine-readable file records and generate source-traceable reimbursement reference points. Clients independently determine reimbursement amounts under their own policies. The methodology supplements existing approaches, including negotiated rates and Medicare-based methods. Claritev expects to make it available across multiple cost-containment applications over time.
Claritev (NYSE: CTEV) appointed Jennifer (Jenni) Main to its Board of Directors, effective October 15, 2026, filling a newly created directorship. Main brings more than three decades of experience across healthcare, technology, government and finance.
She has served as Chief Financial Officer of RealMDai, doing business as Certuma, and Overture Life since March 2026. Her previous roles include Chief Financial Officer and Chief Operating Officer of Amalgam Rx from 2021 to 2026 and Chief Operating Officer of the Centers for Medicare & Medicaid Services from 2018 to 2021.
Claritev (CTEV) has been selected by General Dynamics Information Technology (GDIT) to support the CDC’s World Trade Center (WTC) Health Program by administering its Nationwide Provider Network (NPN).
Claritev will use its existing provider network to connect 9/11 responders and survivors who live outside the New York metropolitan area with healthcare providers experienced in conditions related to 9/11 exposures. The company’s responsibilities include network development, credentialing, and maintaining provider access nationwide for members receiving care for certified WTC-related health conditions. Claritev currently serves more than 750 healthcare payers, over 100,000 employers, 60 million consumers, and 1.4 million contracted providers.
Claritev (CTEV) released its 2025 Corporate Responsibility Report, outlining progress in responsible AI, employee engagement, community impact, and sustainable operations across its healthcare technology business.
Key 2025 actions include formalizing a dedicated Responsible AI function, appointing the company’s first Head of Responsible AI, and joining the Coalition for Health AI. Claritev also launched the Workforward program and an enterprise-wide engagement strategy focused on Career, Cause, and Community, and created the Claritev Cares Foundation, a 501(c)(3) focused on improving healthcare access and equity.
The company reports continued workplace recognition and states that the full report is available on its website.
Claritev (CTEV) appointed AI expert Ben Letham to its Board of Directors, effective 14 September 2026, filling an existing Board vacancy.
Letham is a research scientist at Meta (META) and co-creator of Prophet, an open-source forecasting tool aimed at enabling non-experts to derive insights from data. His background spans large-scale digital experimentation, applied data analysis, and interpretable models for decision-making, including early work at Massachusetts General Hospital and a Ph.D. in Operations Research from MIT. Claritev said his appointment is intended to support its tech-driven, AI-focused growth strategy and the development of AI-led products and enterprise AI transformation in healthcare.
Claritev (CTEV) announced its 2026 Claritev Cares Rural Health Grants for Fairfield Memorial Hospital in Illinois and Kodiak Community Health Center in Alaska.
Fairfield Memorial will use the funding to complete purchase of a portable point-of-care ultrasound system that clinicians can bring directly to patients across the hospital, closing a local fundraising gap. Kodiak Community Health Center will apply its grant to continue the MAVEN Project for another year, enabling local clinicians to consult volunteer specialists while patients remain on Kodiak Island. In the first eight months, 42 consultations were initiated and 82% avoided formal referrals. Claritev Cares selects recipients based on local need, expected impact, and ability to quickly translate funds into patient care, extending a rural grantmaking effort that began in 1995.
Claritev (NYSE: CTEV)/b) announced that its management team will meet investors at several healthcare conferences in September 2026. These include the Wells Fargo 21st Annual Healthcare Conference on September 9 in Boston, the J.P. Morgan 4th Annual Healthcare Credit Conference on September 10 in Nashville, and the Morgan Stanley 24th Annual Global Healthcare Conference on September 15 in New York, featuring a 9:15 a.m. ET presentation and one-on-one meetings, with a webcast available via the company’s investor website.